Nine isolates of XDRAB were derived from clinical specimen (septum, endotracheal aspirate or respiratory lavage fluid) of patients from the critical care units, geriatrics, internal medicine and emergency department at the First Affiliated Hospital of Chengdu Medical College in 2018 to 2019 (Chengdu, Sichuan, China). These isolates were identified by standard laboratory methods and ATB New (bioMérieux, France) and also were further verified by PCR of two genes, 16S rRNA (with primers 5′-CATTATCACGGTAATTAGTG-3′ and 5′-AGAGCACTGTGCACTTAAG-3′) and blaOXA-51 (with primers 5′-TAATGCTTTGATCGGCCTTG-3′ and 5′-TGGATTGCACTTCATCTTGG-3′)42 (link),43 (link). Staphylococcus aureus ATCC29213 and Escherichia coli ATCC25922 used as quality control strains in antimicrobial susceptibility testing were obtained from the American Type Culture Collection (USA).
Free full text: Click here